U.S. Adverse Event Reporting Regulations for Drugs, Dietary Supplements and Cosmetics
Website https://www.complianceonline.com/us-adverse-event-reporting-regulations-for-drugs-dietary-supplement |
Edit Freely
Category
Deadline: June 04, 2019 | Date: June 04, 2019
Venue/Country: U.S.A
Updated: 2019-05-23 22:08:05 (GMT+9)
Call For Papers - CFP
In order to market dietary supplements and OTC drugs in the U.S., reporting serious adverse events is required. It’s essential to understand these important FDA requirements to assure regulatory compliance and avoid an FDA warning letter or 483 audit issues.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.